Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.76 USD
Change Today -0.03 / -3.80%
Volume 29.3K
OGEN On Other Exchanges
Symbol
Exchange
Berlin
NYSE Amex
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald P. Evens

Former Director, Oragenics Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 2 different industries.

See Board Relationships
68--

Background*

Ronald P. Evans, Ron serves as a Clinical Professor of University of Florida, College of Pharmacy. Dr. Evens served as the Chief Executive Officer and President of M.A.P.S. 4 Biotec, Inc. He has over 25 years of substantial Management and Biopharma Industry experience. He served as the Chief Executive Officer and President of Oragenics Inc., from January 1, 2008 to February 12, 2008. He had a distinguished industrial career, including 13 years at Amgen, a leading Human ...

Read Full Background

Corporate Headquarters*

4902 Eisenhower Boulevard
Tampa, Florida 33634

United States

Phone: 813-286-7900
Fax: 813-286-7904

Board Members Memberships*

2007-2008
Former Director

Education*

Unknown/Other Education
University of Kentucky

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGEN:US $0.76 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter Rothschild M.B.A.Founder, Chief Executive Officer, President, Managing Director and Editor-in-Chief
BioGaia AB
kr2.1M
Barry C. Richardson Chief Executive Officer
BLIS Technologies Limited
--
Compensation as of Fiscal Year 2012.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORAGENICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.